Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001557240-15-000413
Filing Date
2015-06-15
Accepted
2015-06-15 10:56:53
Documents
9
Period of Report
2014-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbya_Q2_Nov2014.htm 10-Q 351405
2 EX-31.1 ex_31-1.htm EX-31.1 9601
3 EX-32.1 ex_32-1.htm EX-32.1 3611
  Complete submission text file 0001557240-15-000413.txt   2367424

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT pbya-20141130.xml EX-101.INS 237806
5 XBRL TAXONOMY EXTENSION SCHEMA pbya-20141130.xsd EX-101.SCH 32417
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbya-20141130_cal.xml EX-101.CAL 18878
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbya-20141130_def.xml EX-101.DEF 76737
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbya-20141130_lab.xml EX-101.LAB 198817
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbya-20141130_pre.xml EX-101.PRE 147447
Mailing Address 2801 LAKESIDE DRIVE, SUITE 207B BANNOCKBURN IL 60015
Business Address 2801 LAKESIDE DRIVE, SUITE 207B BANNOCKBURN IL 60015 (312) 371-6829
PANTHER BIOTECHNOLOGY, INC. (Filer) CIK: 0001530981 (see all company filings)

EIN.: 331221758 | State of Incorp.: NV | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-55074 | Film No.: 15930488
SIC: 8700 Services-Engineering, Accounting, Research, Management